Searched for
JUBILANT PHARMA
Small & midcaps rally! Coforge, Ola Electric, FirstCry & other stocks jump up to 7%Small and midcap stocks rose sharply on Tuesday, lifting broader markets and outperforming benchmarks. Coforge led midcap gains, while Ola ...- JioBlackRock Flexi Cap Fund exits 3 AMC stocks, HAL, and 13 others in AprilJioBlackRock Mutual Fund’s Flexi Cap Fund completely exited 17 stocks in April, including AMC companies and Hindustan Aeronautics, while ad...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- AMFI reshuffle: Mazagon Dock, GAIL may slip to midcap; Vodafone Idea eyes largecap upgradeMazagon Dock Shipbuilders and GAIL are among eight stocks that may be downgraded to the midcap category, while Vodafone Idea, currently a m...
- Ceasefire calm or chaos? 50 stocks that brokerages expect to rally after Iran truceA two-week US-Iran ceasefire has sparked a relief rally in Indian equities, though its sustainability is questioned as oil prices rebound. ...
- Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challengesPankaj Pandey shares insights on Indian sectors facing US tariffs. He sees limited impact on pharma growth but potential benefits for Jubil...
- Jubilant gets VAI classification from USFDA for Roorkee unitAs per the USFDA, a VAI inspection classification indicates that although investigators found and documented objectionable conditions durin...
- Jubilant Pharmova sells stake in Sofie Biosciences for $139.4 millionJPL holds a 25.8% stake in Sofie Biosciences, which it acquired through its Singapore-based subsidiary Jubilant Pharma in November 2020 for...
- Jubilant Pharma arm to raise USD 400 million loan from Standard Chartered Bank to repay debtWhile the term loan and bonds aggregate to USD 350 million, about Rs 2,787 crore, the company is raising another tranche of USD 50 million ...
- Jubilant Pharmova surges as company develops Remdesivir oral formHospitals and pharmacists in major cities have reported acute shortage of the drug due to supply constraints and alleged hoarding.
- Sun Pharma, Dr Reddy's, Aurobindo recall products in the US marketAs per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, whi...
- Jubilant Pharma gets USFDA nod for Symmetrel's generic versionThe approved drug, generic version of Symmetrel of Endo, is indicated for the prophylaxis and treatment of signs and symptoms of infection ...
- Jubilant Pharma completes Triad's US radiopharmacy acquisitionThe acquired radiopharmacies will continue to operate independently under the brand name of Triad Isotopes.
- Jubilant Life Sciences may list pharma unit in SingaporeSingapore-based Jubilant Pharma could award mandates as early as next month.
- Jubilant Life Sciences looks to buy specialty pharma business in USThe potential acquisition will be subject to due diligence, satisfactory agreements, etc and final approval of Jubilant Life Sciences.
- Jubilant Life signs deals for diagnostic product supplyJubilant DraxImage Montreal Canada has signed long-term contracts with distribution networks in the US for supply of products used for diag...
- Jubilant Pharma raises $300 million via bonds"The net proceeds of the Notes shall be used to prepay the existing debt of JPL and its subsidiaries," Jubilant Life Sciences said in a BSE...
- Jubilant Pharma names Gurpartap Singh Sachdeva as CEOJubilant Life Sciences has appointed Gurpartap Singh Sachdeva as CEO of Jubilant Pharma, a wholly-owned subsidiary of the pharmaceutical co...
- Jubilant Life Sciences up 6%, hits fresh 52-week high on Rs 860 crore funding from IFCCompany's subsidiary, Jubilant Pharma will receive $147.5 mn funding from IFC to strengthen its generic drug manufacturing facilities.
- Jubilant Life to consolidate pharma business under Singapore unitThe company's board has approved a proposal to transfer its active pharmaceutical ingredient and dosage form business to its Singapore-base...
Load More
